SCHEMBL3845649

SCHEMBL3845649

CS(=O)(=O)c1ccc(CN2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cc34)CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.45
BACE1 P56817 4/20 0.45
LMNA P02545 8/20 0.42
CYP1A2 P05177 5/20 0.42
CYP3A4 P08684 5/20 0.42
MAPK1 P28482 5/20 0.42
CLK4 Q9HAZ1 5/20 0.42
ALDH1A1 P00352 3/20 0.42
HIF1A Q16665 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
AKT1 P31749 1/20 0.41
MAPT P10636 3/20 0.41
TP53 P04637 2/20 0.41
CCR2 P41597 1/20 0.40
HTT P42858 1/20 0.40
AURKA O14965 1/20 0.40
USP2 O75604 3/20 0.40
CYP2D6 P10635 2/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845654 0.86 ACHE (0.38) ACHEBACE1LMNACYP1A2CYP3A4
SCHEMBL3852227 0.84 CYP3A4 (0.42) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3849227 0.83 CHRM4 (0.46) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3847513 0.83 CYP3A4 (0.42) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3852021 0.81 CYP3A4 (0.43) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3845891 0.80 ACHE (0.47) ACHEBACE1LMNACYP1A2CYP3A4
SCHEMBL3846811 0.79 ACHE (0.46) ACHEBACE1LMNACYP1A2CYP3A4
Hydrochloric Acid SCHEMBL3847274 0.78 AKT1 (0.55) ACHEBACE1LMNACYP1A2CYP3A4
SCHEMBL3846795 0.78 CYP1A2 (0.59) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3847121 0.77 MAPT (0.50) ACHEBACE1LMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed